Drug

Polastro dubbed the combined markets of China and India as

Dispatches from DCAT Week

'Chindia' drug substance market not to be discounted

By Melissa Fassbender

China and India are causing a “tsunami” in the drug substance market – yet significant hurdles may bring fine chemical outsourcing back to the West.

Charles River seeing more strategic relationships, CEO says

Charles River seeing more strategic relationships, CEO says

By Zachary Brennan

As Big Pharma and biotech companies continue to outsource more of their work, one of the leaders in the preclinical and discovery space – Charles River Laboratories – is seeing more strategic relationships with both large and small clients, CEO James...

Recipharm given the go-ahead in France

Recipharm gets OK in France

Swedish CDMO Recipharm has been cleared by French regulators to fill biotech drug products at its site in Tours.

Late phase clinical trials: Where the business is at, says PRA

PRA focuses on late phase services

By Natalie Morrison

PRA has expanded its operations in the Netherlands and the UK in a bid to meet what it says is soaring client demand for late phase and product registration services.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers